Effects of Anesthesia on Atelectasis
EVALUATION of PEROPERATIVE ATELECTASIS with LUNG ULTRASOUND SCORE in GENERAL ANAESTHESIA MAINTENANCE METHODS
1 other identifier
observational
90
1 country
1
Brief Summary
We know that respiratory functions of patients are affected under general anaesthesia. Although there are many underlying causes of ventilation-perfusion mismatch in the airways, the main cause is atelectasis during general anaesthesia. Atelectasis occurs in almost all patients receiving general anaesthesia. The main cause of atelectasis is the loss of muscle tone during general anaesthesia. Postoperative atelectasis was described in the last century. It is defined as the closure of the alveoli due to a decrease in inspiratory force and collapse of the lung and the resulting loss of aeration. Inhalation anaesthetics have been shown to cause hypoxic pulmonary vasoconstriction in studies. However, not all inhalation anaesthetics affect the airways in the same way. In patients who will undergo surgical procedures under different general anaesthesia maintenance methods, conditions that disrupt the ventilation-perfusion balance in the lung peroperatively can be diagnosed and monitored early, easily and inexpensively by lung ultrasonography. Lung ultrasound is a noninvasive, reliable, reliable, radiation-free imaging method that provides instantaneous imaging at the bedside. Lung ultrasound score is a scoring system that provides scoring of the loss of ventilation in the lung. For this purpose, it was aimed to divide both lung tissues into 12 areas and to give a score between 0 and 3 points and to show the severity of the loss of aeration according to the resulting total score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2025
CompletedFirst Submitted
Initial submission to the registry
January 13, 2025
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedJanuary 24, 2025
January 1, 2025
12 months
January 13, 2025
January 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peroperative Atelectasis
from induction to postoperative 1st hour
Study Arms (3)
Group Total IV anesthesia
Group Sevoflurane
Group Desflurane
Interventions
Determination of atelectsis By Lung Ultrasound Score
Eligibility Criteria
18-65 years old, ASA I-II, who will undergo rhinoplasty, septorhinoplasty operation
You may qualify if:
- years old ASA I-II Surgical procedure time between 2 hours and 5 hours in supine position Patients who will undergo rhinoplasty, septorhinoplasty operation Patients whose consent was obtained with an informed consent form
You may not qualify if:
- Those with a history of malignant hyperthermia,
- People with alcohol or drug addiction,
- Presence of dementia or confusion,
- Uncooperative patients,
- Those with respiratory disease,
- Those with coronary artery disease, congestive heart failure,
- Patients with unstable blood pressure,
- Significant anaemia, liver or kidney disease,
- Women during pregnancy or lactation,
- Allergy to anaesthetic agents,
- Body mass index (BMI) \>30 kg/m2,
- Those with sepsis or bacterial infection, Body temperature below 35°C and above 38°C at control value
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguladk Bulent ecevit University
Zonguldak, Kozlu, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 13, 2025
First Posted
January 24, 2025
Study Start
September 15, 2023
Primary Completion
August 30, 2024
Study Completion
January 12, 2025
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share